Journal
/
/
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
JoVE Journal
Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Biology
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
DOI:

09:53 min

June 15, 2018

, ,

Chapters

  • 00:04Title
  • 00:56Cloning the Recipient Vector to Include a Tissue-specific Promoter
  • 03:48Cloning the Sponge
  • 04:55Generation of Stable H9c2 miR-181-sponge Expressing Cells
  • 05:53Synthesis and Purification of Sponge-nanoparticles (miR-181-sponge Nanoparticles)
  • 07:01Results: Validation of Nanonvector Delivery of the miR-181-sponge and its Effect on miR-181c Expression
  • 07:58Conclusion

Summary

Automatic Translation

Tissue-specific microRNA inhibition is a technology that is underdeveloped in the microRNA field. Herein, we describe a protocol to successfully inhibit the miR-181 microRNA family in myoblast cells from the heart. Nanovector technology is used to deliver a microRNA sponge that demonstrates significant in vivo cardio-specific miR-181 family inhibition.

Related Videos

Read Article